Medtronic Endeavors To Gain Drug-Eluting Stent Share In Europe

Medtronic's ability to immediately launch 80,000Endeavor drug-eluting stents should help the firm to avoid the supply constraint issues faced by J&J

More from Archive

More from Medtech Insight